×

BMY's very bad, horrible, awful day

1:04 PM ET Fri, 5 Aug 2016

Bristol Myers Squibb is having its worst day in nearly 16 years after failing to meet goals for a lung cancer drug. Alex Arfaei, BMO, discusses.